Y-mAbs Therapeutics, Inc.
Y-mAbs Therapeutics, Inc. (YMAB) is a publicly traded company in the Unknown sector. Across all available filings, 22 corporate insiders have executed 316 transactions totaling $127.3M, demonstrating a bearish sentiment with -$80.2M in net insider flow. The most recent transaction on Sep 16, 2025 involved a transaction of 25,080 shares valued at $0.
YMAB Insider Activity Summary
Who Is Buying YMAB Stock?
No significant insider buying has been recorded for YMAB in the recent period.
Who Is Selling YMAB Stock?
No significant insider selling has been recorded for YMAB in the recent period.
Is Y-mAbs Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for YMAB is bearish with an Insider Alignment Score of 19/100 and a net flow of -$80.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
YMAB Frequently Asked Questions
Understanding YMAB Insider Activity
Insider trading at Y-mAbs Therapeutics, Inc. (YMAB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 22 insiders are actively trading YMAB stock, having executed 316 transactions in the past 90 days. The most active insider is Johan Wedell-wedellsborg (Executive), who has made 38 transactions totaling $66.1M.
Related Tools
Track Y-mAbs Therapeutics, Inc. Insider Activity
Get notified when executives and directors at YMAB file new Form 4 transactions